Verity Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Verity Asset Management's BMY Position: Q2 2026 in Review
Verity Asset Management increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, buying an estimated $61.5K and bringing the position to 31,404 shares worth $1.81M. The position accounts for 0.68% of the portfolio, ranked #43.
Verity Asset Management first reported a position in BMY in Q3 2016 and has held it in 18 quarters since. The position peaked at $2.27M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Verity Asset Management held 31,404 shares of Bristol-Myers Squibb worth $1.81M as of Q2 2026.
- Verity Asset Management bought 1,071 Bristol-Myers Squibb shares in Q2 2026, an estimated $61.5K.
- Bristol-Myers Squibb made up 0.68% of Verity Asset Management's portfolio in Q2 2026, its #43 holding.
- Verity Asset Management first reported a position in Bristol-Myers Squibb in Q3 2016 and has held it in 18 quarters since.
- Verity Asset Management's Bristol-Myers Squibb position peaked at $2.27M in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.